Abiopharma

New Form EFFECT - GCL Global Holdings Ltd <b>Filed:</b> 2026-06-09 <b>AccNo:</b> 9999999995-26-001925 <b>Size:</b> 1 KB

Logitech Launches Mobi Fold, Its First Ultra-Portable Foldable Mouse for Life On the Go

Skyworks Showcases Software-Defined Power Portfolio for AI Infrastructure and Intelligent Mobility at PCIM Europe 2026

Captivate Your Audience with the New Logitech Spotlight 2 Advanced Presenter, Featuring Haptics and Digital Highlighting

Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model

The company intends to hold a tender for institutional investors on 10.6.26 regarding an examination for issuing BONDS series 27.

Completion of the transaction for the sale of the fund’s entire holdings in Porterbrook

Became an interested party – Clal Insurance Enterprises Holdings Ltd.

Holding(s) in Company

Europe’s Payments Leaders Gather in London as Control, Fraud and AI Reshape the Industry

Ingredion gibt empfohlene bar finanzierte Übernahme von Tate & Lyle bekannt

Ingredion annonce une offre publique recommandée d’acquisition de Tate & Lyle intégralement en numéraire

TGS Begins First Phase of Major Offshore Seismic Dataset in Equatorial Guinea

Applied Materials Expands Singapore Manufacturing to Support AI Chip Demand

Communiqué de presse : Sanofi fait le point sur l’étude de phase 3 MOBILIZE, qui évalue le riliprubart dans la polyneuropathie inflammatoire démyélinisante chronique